Attana expands collaboration with HVD Life Sciences
Attana has on Monday March 12 signed a five year exclusive distribution agreement with HVD Life Sciences. The agreement appoints HVD Life Sciences as Attana´s representant in Asia, Russia including CIS/NIS, Eastern Europe, South East Europe and Austria. Since previously Attana and HVD Life Sciences has a distribution agreement for some countries in Eastern Europe.
During the fall 2017 Attana concluded a financing round in order to expands the companies resources within sales and marketing. The collaboration with HVD Life Sciences is in agreement with the plans Attana communicated during last fall and means that Attana´s sales efforts will be significantly strengthened. The collaboration between the companies has been ongoing for a couple of years in East Europe and HVD Life Sciences already have Attana trained sales and service staff. Attana will contribute with technical sales- and customer applications support. HVD Life Sciences headquater is in Austria. For more information about HVD Life Sciences, visit http://www.hvdlifesciences.com.
For more information, please contact:
Teodor Aastrup, CEO Attana AB
tel: + 46 8 674 57 00
This is information that Attana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at March 13 CET on 07.00 2018
Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit www.attana.com or contact email@example.com.